A Study of the Pharmacokinetics and Safety of SM03 in Patients With Rheumatoid Arthritis
Clinical trial NCT04704492 · COMPLETED
Trial details
- NCT number
- NCT04704492
- Sponsor
- SinoMab BioScience Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-14
- Primary completion
- 2013-12-16
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.